Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany

Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergi...

Descripción completa

Detalles Bibliográficos
Autores principales: Worm, Margitta, Bauer, Andrea, Wedi, Bettina, Treudler, Regina, Pfuetzner, Wolfgang , Brockow, Knut, Buhl, Timo, Zuberbier, Torsten, Fluhr, Joachim, Wurpts, Gerda, Klimek, Ludger, Jakob, Thilo, Merk, Hans F., Mülleneisen, Norbert, Roeseler, Stefani, Dickel, Heinrich , Raap, Ulrike, Kleine-Tebbe, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2021
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841415/
https://www.ncbi.nlm.nih.gov/pubmed/33521511
http://dx.doi.org/10.5414/ALX02225E
Descripción
Sumario:Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire.

Ejemplares similares